Topical Drug Recalled: Americaine Benzocaine Spray Contaminated with Benzene
Americaine benzocaine 20% topical anesthetic spray is being recalled nationwide due to benzene chemical contamination. The recall affects 34,704 cans with lot number 1A16420 and expiration date 01/31/2025.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA Class I classification requires a minimum severity score of 4 per the rubric. The source indicates benzene contamination in this pharmaceutical product.
Plain-English summary
Americaine (benzocaine 20%) topical anesthetic spray distributed by Insight Pharmaceuticals LLC is being recalled nationwide due to chemical contamination with benzene. The product was manufactured in India.
The affected product is the 2 oz (57 g) aerosol spray with lot number 1A16420 and expiration date 01/31/2025. This recall involves 34,704 cans distributed nationwide. Consumers with this product should consult their healthcare provider regarding the contamination.
The recalled product
- Product
- AMERICAINE (BENZOCAINE)
- Brand
- AMERICAINE
- Manufacturer
- Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company
- Category
- Drug — Topical Anesthetic
- Hazard
- benzene
- chemical-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 1A16420
- exp. date 01/31/2025
UPCs (1)
- 363736378820
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27